This reply
Lin mark this message contains misinformation
originally written by Lin
假的。LOXO-101是一個靶向藥,只針對NTRK1、NTRK2或者NTRK3基因融合的腫瘤患者。

References

http://js.xhby.net/system/2018/11/28/030900416.shtml
只適合特殊少數基因突變癌症患者

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.